Shock Syndromes I

vasodilatory shock: a randomized, controlled, open-

doi.org/10.1007/s00134-009-1630-1

Townsend SR, Rivers E, Tefera L. Definitions for sepsis

doi.org/10.1001/jama.2016.6374

Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld

G, Wunsch H. Association between US norepinephrine

shortage and mortality among patients with septic shock.

jama.2017.2841

Venkatesh B, Finfer S, Cohen J, et al. Adjunctive gluco-

corticoid therapy in patients with septic shock. N Engl

J Med. 2018;378(9):797-808. https://doi.org/10.1056/

nejmoa1705835

Vieillard-Baron A, Caille V, Charron C, Belliard G,

Page B, Jardin F. Actual incidence of global left ven-

Med.

2008;36(6):1701-1706.

https://doi.org/10.1097/

ccm.0b013e318174db05

Vincent JL, Rello J, Marshall J, et al. International study

of the prevalence and outcomes of infection in intensive

org/10.1001/jama.2009.1754

Werdan K, Pilz G, Bujdoso O, et al. Score-based immu-

noglobulin G therapy of patients with sepsis: the SBITS

Whitson MR, Mo E, Nabi T, et al. Feasibility, utility,

and safety of midodrine during recovery phase from

septic shock. Chest. 2016;149(6):1380-1383. https://doi.

org/10.1016/j.chest.2016.02.657

Zampieri FG, Cavalcanti AB, Di Tanna GL, et al.

Balanced crystalloids versus saline for critically ill

patients (BEST-Living): a systematic review and indi-

Med.

2024;12(3):237-246.

https://doi.org/10.1016/

s2213-2600(23)00417-4